ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS
DNA 双链断裂激活细胞信号通路
基本信息
- 批准号:8444678
- 负责人:
- 金额:$ 29.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAntigen ReceptorsCell LineCellsChromatinChromatin StructureDNADNA DamageDNA Double Strand BreakDNA RepairDNA SequenceDNA biosynthesisDNA lesionDNA-PKcsDataDevelopmental ProcessDouble Strand Break RepairExhibitsFoundationsG1 PhaseGene ExpressionGene TargetingGenerationsGenesGenetic ProgrammingGenomeGenome StabilityGenomic InstabilityHealthHistonesImmunoglobulin Class SwitchingImmunoglobulin Switch RecombinationImmunoglobulinsKnowledgeLightLocationLymphocyteLymphocyte antigenLymphomaMaintenanceMalignant - descriptorMalignant NeoplasmsMediatingMeiosisModificationMolecularMusMutagensPathway interactionsPhosphorylationPhosphotransferasesPhysiologicalPhysiological ProcessesPredispositionProcessProteinsReagentReceptor GeneRegulationRiskSignal PathwaySignal TransductionSignaling ProteinSiteSolid NeoplasmTestingTrans-ActivatorsTranscriptional ActivationTranscriptional RegulationV(D)J RecombinationVariantataxia telangiectasia mutated proteinbasedensityhuman H2AX proteinnovelpreventprotein functionrepairedresponsetranscription factorubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant):
The main objective of this proposal is to elucidate the mechanisms by which the histone H2AX protein signals cellular responses to DNA double strand breaks (DSBs). DSBs are generated by genotoxic agents and are intermediates during physiologic processes such as DNA replication, meiosis and the generation (VDJ recombination) and diversification (class switch recombination) of lymphocyte antigen receptor genes. We have shown that H2AX deficient mice exhibit genomic instability and an increased predisposition cancer, including lymphomas clonal translocations, some of which involve antigen receptor loci. These data indicate that H2AX is involved in the repair of and/or cellular response to genotoxic and physiologic DSBs. H2AX is phosphorylated (generating ?-H2AX), acetylated, and ubiquitylated in chromatin around DSBs; however, the function(s) of ?-H2AX and these other modified forms of H2AX are not known. H2AX deficient mice are lymphopenic and 3-H2AX forms at antigen receptor loci undergoing V(D)J recombination, suggesting that H2AX functions in the repair of and/or cellular response to DSBs generated during lymphocyte antigen receptor gene assembly. We have shown that the kinase activity of ATM is required for the repair of DSBs generated during antigen receptor gene assembly and for the activation of a broadly functional genetic program in response to these physiologic DSBs. Since ATM is the major kinase that phosphorylates H2AX, our data raise the possibility that the ATM functions through the phosphorylation of ?-H2AX to mediate these processes. Within this application, we show that H2AX is not required for the repair of DSBs generated during antigen receptor gene assembly, but is required to activate gene expression in response to these physiologic DSBs. Thus, we hypothesize that H2AX is an important intermediate in activating transcriptional pathways in response to DSBs due, at least in part, to a requirement to generate 3-H2AX in chromatin around these DNA lesions. Here, we propose to use a novel cell line based approach whereby DSBs can be induced at precise locations in the genome and elucidate the cis-acting and trans-acting factors that regulate the formation of ?-H2AX at these breaks. In addition, we propose to elucidate the transcriptional pathways that are activated by ?-H2AX, determine how they are activated, and identify the target genes that are regulated by these pathways.
描述(由申请人提供):
本提案的主要目的是阐明组蛋白H2 AX蛋白信号细胞响应DNA双链断裂(DSB)的机制。DSB由遗传毒性剂产生,是生理过程中的中间体,如DNA复制、减数分裂和淋巴细胞抗原受体基因的产生(VDJ重组)和多样化(类别转换重组)。我们已经表明,H2 AX缺陷小鼠表现出基因组不稳定性和增加的易感性癌症,包括淋巴瘤克隆易位,其中一些涉及抗原受体基因座。这些数据表明,H2 AX参与修复和/或细胞反应的遗传毒性和生理DSB。H2 AX被磷酸化(产生?H2 AX)、乙酰化和泛素化;然而,H2 AX和H2 AX的这些其他修饰形式是未知的。H2 AX缺陷型小鼠是淋巴细胞减少的,并且在经历V(D)J重组的抗原受体基因座处形成3-H2 AX形式,表明H2 AX在淋巴细胞抗原受体基因组装期间产生的DSB的修复和/或细胞应答中起作用。我们已经表明,ATM的激酶活性是修复抗原受体基因组装过程中产生的DSB和激活响应于这些生理DSB的广泛功能的遗传程序所必需的。由于ATM是磷酸化H2 AX的主要激酶,我们的数据提出了ATM通过磷酸化?H2 AX介导这些过程。在此应用中,我们表明,H2 AX是不需要的抗原受体基因组装过程中产生的DSB的修复,但需要激活基因表达,以响应这些生理DSB。因此,我们假设,H2 AX是一个重要的中间体,在激活转录途径响应DSB,由于,至少部分地,在这些DNA损伤周围的染色质中产生3-H2 AX的要求。在这里,我们建议使用一种新的细胞系为基础的方法,DSB可以诱导在基因组中的精确位置,并阐明顺式作用和反式作用的因素,调节?H2 AX在这些休息。此外,我们建议阐明的转录途径,激活?- H2 AX,确定它们是如何被激活的,并确定由这些途径调节的靶基因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CRAIG H BASSING其他文献
CRAIG H BASSING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CRAIG H BASSING', 18)}}的其他基金
Elucidating Mechanisms of RAG Endonuclease Mediated Feedback Inhibition of V(D)J Recombination
阐明 RAG 核酸内切酶介导的 V(D)J 重组反馈抑制机制
- 批准号:
10538891 - 财政年份:2022
- 资助金额:
$ 29.94万 - 项目类别:
Exploring a Functional Role of Chromosome Loop Extrusion Direction on Regulating Genome Biology
探索染色体环挤出方向在调节基因组生物学中的功能作用
- 批准号:
10606672 - 财政年份:2022
- 资助金额:
$ 29.94万 - 项目类别:
Elucidating Mechanisms of RAG Endonuclease Mediated Feedback Inhibition of V(D)J Recombination
阐明 RAG 核酸内切酶介导的 V(D)J 重组反馈抑制机制
- 批准号:
10664014 - 财政年份:2022
- 资助金额:
$ 29.94万 - 项目类别:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
阐明淋巴细胞等位排除机制和功能
- 批准号:
10684807 - 财政年份:2019
- 资助金额:
$ 29.94万 - 项目类别:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
阐明淋巴细胞等位排除机制和功能
- 批准号:
10231184 - 财政年份:2019
- 资助金额:
$ 29.94万 - 项目类别:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
阐明淋巴细胞等位基因排除机制和功能
- 批准号:
10466824 - 财政年份:2019
- 资助金额:
$ 29.94万 - 项目类别:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
阐明淋巴细胞等位基因排除机制和功能
- 批准号:
10020899 - 财政年份:2019
- 资助金额:
$ 29.94万 - 项目类别:
Elucidating Lymphocyte Allelic Exclusion Mechanisms and Functions
阐明淋巴细胞等位排除机制和功能
- 批准号:
9917182 - 财政年份:2019
- 资助金额:
$ 29.94万 - 项目类别:
Topological Control of Antigen Receptor Loci during Lymphocyte Development
淋巴细胞发育过程中抗原受体位点的拓扑控制
- 批准号:
10238038 - 财政年份:2017
- 资助金额:
$ 29.94万 - 项目类别:
Topological Control of Antigen Receptor Loci during Lymphocyte Development
淋巴细胞发育过程中抗原受体位点的拓扑控制
- 批准号:
9753111 - 财政年份:2017
- 资助金额:
$ 29.94万 - 项目类别:
相似海外基金
Development of back bone vectors for chimeric antigen receptors against key molecules, CD47 and CD24, activating macrophages
开发针对关键分子 CD47 和 CD24 的嵌合抗原受体的骨干载体,激活巨噬细胞
- 批准号:
23K06728 - 财政年份:2023
- 资助金额:
$ 29.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAREER: Engineering next-generation chimeric antigen receptors for cancer immunotherapy using phospho-proteomics
职业:利用磷酸蛋白质组学设计用于癌症免疫治疗的下一代嵌合抗原受体
- 批准号:
2145853 - 财政年份:2022
- 资助金额:
$ 29.94万 - 项目类别:
Continuing Grant
Construction of a drug discovery platform utilizing antigen receptors that regulate the quality of cancer immunity
利用调节癌症免疫质量的抗原受体构建药物发现平台
- 批准号:
22K06603 - 财政年份:2022
- 资助金额:
$ 29.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Engineering synthetic adhesion receptors to enhance the sensitivity of therapeutic chimeric antigen receptors
工程合成粘附受体以增强治疗性嵌合抗原受体的敏感性
- 批准号:
MR/W031353/1 - 财政年份:2022
- 资助金额:
$ 29.94万 - 项目类别:
Research Grant
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
- 批准号:
10701754 - 财政年份:2022
- 资助金额:
$ 29.94万 - 项目类别:
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
- 批准号:
10557760 - 财政年份:2022
- 资助金额:
$ 29.94万 - 项目类别:
Chimeric antigen receptors on regulatory T cells as a treatment strategy in auto-immune diseases.
调节性 T 细胞上的嵌合抗原受体作为自身免疫性疾病的治疗策略。
- 批准号:
437200 - 财政年份:2020
- 资助金额:
$ 29.94万 - 项目类别:
Studentship Programs
Molecualr imaging for development of chimeric antigen receptors (CARs) resistant to T cell exhaustion
用于开发抗 T 细胞耗竭的嵌合抗原受体 (CAR) 的分子成像
- 批准号:
20H03536 - 财政年份:2020
- 资助金额:
$ 29.94万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
- 批准号:
10542442 - 财政年份:2020
- 资助金额:
$ 29.94万 - 项目类别:
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
- 批准号:
10321545 - 财政年份:2020
- 资助金额:
$ 29.94万 - 项目类别: